Skip to main content

CGT Catapult: Past and present experience of ATMP in the UK to inform future best practice

The Cell and Gene Therapy Catapult (CGT Catapult) is an independent not-for-profit innovation and technology organisation committed to the advancement of cell and gene therapies. 

This round table report published by CGT Catapult summarises discussions between industry, NHS, regulators and patient groups on the past, present and future challenges in the UK ATMP ecosystem.

A press release is available here.

cgt catapult

CGT Catapult's roundtable summary: How can we use past & current experience to inform future best practice and ensure system readiness for routine ATMP clinical adoption? 

Le contenu de cette page vous a-t-il été utile ? Envoyez-nous vos commentaires
-
Your feedback helps us keep EuroGCT online. Please can you take 30 seconds to answer these quick questions?
How would you rate your experience using EuroGCT.org today?
Poor
Great
Is the information on this website understandable?
Not at all understandable
Very understandable
Is the information on this website useful?
Not at all useful
Very useful
Is the website easy to use and navigate?
Not at all easy
Very easy
Why are you interested in gene and cell therapies and research?
CAPTCHA
Cette question sert à vérifier si vous êtes un visiteur humain ou non afin d'éviter les soumissions de pourriel (spam) automatisées.